Cumberland Pharmaceuticals
CPIXCumberland Pharmaceuticals is a specialty pharmaceutical company that acquires, develops, and commercializes branded prescription products for hospital acute care, gastroenterology, and oncology markets.
Earnings
Next report
Aug 4, 2026 (In 6 days)Valuation & ratios
Segments
By product
Competitors
By market cap
By revenue growth
By net margin
Profile
Cumberland Pharmaceuticals is a specialty pharmaceutical company that acquires, develops, and commercializes branded prescription products for hospital acute care, gastroenterology, and oncology markets. The company leverages a targeted sales infrastructure and international partnerships to deliver unique medicines that address unmet medical needs in concentrated prescriber bases.
Cumberland maintains a niche position by focusing on concentrated medical specialties that can be served by small, targeted sales forces and by acquiring orphan or specialty drugs.
Questions, answered.
- What is Cumberland Pharmaceuticals's market cap?
- Cumberland Pharmaceuticals (CPIX) has a market capitalization of $105.3M and trades on NASDAQ.
- What is Cumberland Pharmaceuticals's revenue and profitability?
- Cumberland Pharmaceuticals generated $41.9M in trailing twelve-month revenue with a net loss of $7.4M, representing a net margin of -17.6%. Gross margin stands at 82.9%, with free cash flow of $1.4M. These figures are based on the Q1 2026 filing.
- Who are Cumberland Pharmaceuticals's competitors?
- Cumberland Pharmaceuticals's key competitors include Baxter International, BridgeBio Pharma, Inc. Common Stock, Scienture Holdings, Inc. Common Stock, and others. These companies compete in similar markets and product categories.
- Who does Cumberland Pharmaceuticals partner with?
- Cumberland Pharmaceuticals's notable partners include Perrigo Company, Poly Pharmaceuticals, Foxland Pharmaceuticals, Inc., and others.
- What subsidiaries does Cumberland Pharmaceuticals have?
- Cumberland Pharmaceuticals's subsidiaries include Cumberland Emerging Technologies, Talicia Holdings, Inc..
- Where is Cumberland Pharmaceuticals headquartered?
- Cumberland Pharmaceuticals is headquartered in United States of America and employs approximately 91 people. It has been publicly traded since 2009.
